pharmaceutical company
Explore how the latest evidence is shaping modern MASH management. Learn from leading experts as they discuss evolving treatment strategies ... Show more
MASH in the Modern Era
MASH in the Modern Era
MLB.com 18h
Justin Martinez hasn't allowed a run in 7 appearances since joining the Diamondbacks bullpen
A heater like this helps 🔥🔥🔥
(MLB x AbbVie)
China approves J&J psoriasis pill Icotyde, says drugmaker: Wall Street analysts have said J&J’s drug, Icotyde, has 'blockbuster potential' as a safe ...
timeslive.co.za/news/world/2026-08-27-china-approves-jj-psoriasis-pill-icotyde-says-drugmaker/
Gubra: AbbVie milestone - | Stock with buy signal: Gubra achieves an important milestone with AbbVie: The obesity program ABBV-295 enters Phase 2 ...
deraktionaer.de/artikel/pharma-biotech/gubra-meilenstein-von-abbvie-aktie-mit-kaufsignal-20407416.html
MLB.com Aug 20
A real dream come true! AbbVie hosted cancer survivor and former college baseball player Nick for an all-access experience with MLB at Field of Dreams ... Show more
Major League Baseball
Major League Baseball
In the slipstream of Eli Lilly and Novo Nordisk: AbbVie and Gubra before the next big step
deraktionaer.de/artikel/pharma-biotech/im-windschatten-von-eli-lilly-und-novo-nordisk-abbvie-und-gubra-vor-dem-naechsten-grossen-schritt-20406552.html
Paid articlePaywall
AbbVie $ABBV reported strong Q2 results, driving net revenues up +10.2% YoY to nearly $17B!
KEY HIGHLIGHTS:
Skyrizi sales surged +24% to $5 ... Show more
STAT Aug 06
Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts
statnews.com/pharmalot/2026/08/06/medicare-gave-blockbuster-abbvie-drug-seven-extra-years-before-price-negotiations/
Paid articlePaywall
These 5 stocks are profiting from the new beauty boom - | one of them is still a real insider tip for investors
fr.de/wirtschaft/diese-aktien-profitieren-vom-neuen-beauty-boom-eine-davon-ist-noch-ein-echter-geheimtipp-fuer-anleger-zr-94422859.html
CA wineries burning their own vineyards due to low sales: Facing plummeting wine sales, California vineyards are reportedly destroying vines as changing consumer ...
qz.com/abbvie-earnings-profit-forecast-apogee-acquisition-073126
Nasdaq Breaks Support As Chip Sell-Off Deepens; Knight-Swift, CP, ABBV In Focus | Stock Market Today
Sarepta names former Abbvie president as CEO as Ingram retires: Sarepta Therapeutics said on Monday it appointed former Tessera Therapeutics CEO Michael ...
reuters.com/legal/transactional/sarepta-names-former-abbvie-president-ceo-ingram-retires-2026-07-27/
Buy these quality, low-stress stocks for the summer, says Jefferies: This summer, Jefferies recommends focusing on some high-quality stocks that have been left ...
cnbc.com/2026/07/07/buy-these-quality-low-stress-stocks-for-the-summer-says-jefferies.html
AbbVie Goes On The Offensive With $10.9 Billion Takeover: AbbVie announced Monday a $10.9 billion plan to acquire immunology-focused Apogee Therapeutics ...
investors.com/news/technology/abbvie-apogee-therapeutics-acquisition-apogee-stock/
Healthcare stocks have become a haven for investors ditching tech: AbbVie, Lilly and J&J’s shares all closed at all-time highs
marketwatch.com/story/healthcare-stocks-have-become-a-haven-for-investors-ditching-tech-81c544d0
Paid articlePaywall STAT Jun 22
Another big deal, another sign biotech M&A is back: Today's biotech news includes AbbVie buying Apogee Therapeutics, LSD therapy Phase 3 results ...
statnews.com/2026/06/22/biotech-news-another-big-deal-another-sign-ma-is-back/
Paid articlePaywall
Fake Botox batch in UAE: Authorities order immediate halt to its use: UAE's drug authority has issued an urgent warning against a counterfeit batch of Botox ...
khaleejtimes.com/uae/uae-warns-counterfeit-botox-cosmetic-batch-c7048c4
AbbVie would gain an experimental eczema drug by buying biotech: report: If approved, the drug would be a new option for people with atopic dermatitis
marketwatch.com/story/abbvie-would-gain-an-experimental-eczema-drug-by-buying-biotech-report-caf24728
Paid articlePaywall
6 Newly Overvalued Stocks this Week: ASML and Marvell Technology are among the stocks now rated as expensive.
morningstar.com/stocks/19-newly-overvalued-stocks-this-week
STAT May 26
The innovation trap: How pharma weaponizes a word to extend monopolies: Although Humira has become the poster child for patent abuse, this process is not ...
statnews.com/2026/05/26/humira-patents-abbvie-innovation-pharma-monopoly-excerpt/
MLB.com Jun 03
Kyle Harrison strikes out 12 in a start for the second time this season!
(MLB x AbbVie)
MLB.com May 25
After another double-digit strikeout performance, Jacob Misiorowski is the first pitcher to reach 100 Ks this season!
(MLB x AbbVie)
AbbVie: Migraine drug proves its worth in clinical trial: Migraines plague millions. The EU decision on the approval of an AbbVie drug for the treatment of acute ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/klinische-studie-zu-migraene-arznei-weckt-hoffnungen-5693382
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
investors.com/news/technology/biotech-stock-avalo-therapeutics-hs-treatment/
Barron's Apr 29
AbbVie Beats Earnings Estimates, Boosts 2026 Outlook. What It Means for the Stock.
barrons.com/articles/abbvie-earnings-stock-price-d3cbc66c
Paid articlePaywall
Investors often look for dividend-paying stocks during uncertain markets, especially companies with strong cash flow and steady shareholder payouts ... Show more
Here are Thursday's biggest analyst calls: Nvidia, Amazon, Microsoft, Meta, Alphabet, Palantir, AbbVie & more
cnbc.com/2026/04/30/thursday-stocks-by-analyst-calls-like-meta-amazon.html
Paid articlePaywall
Pharma giant AbbVie picks Durham for $1.4 billion investment with hundreds of jobs
charlotteobserver.com/news/business/article315495282.html
Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?
dlvr.it/TS2dYD
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - AbbV
benzinga.com/trading-ideas/dividends/26/04/51827538/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-3-dividend-yields-7
Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?: ABBV eyes a strong Q1 performance as neuroscience sales, led by Botox and Vraylar ...
qz.com/will-abbvie-s-neuroscience-franchise-aid-top-line-growth-in-q1
Exclusive: AbbVie sues to narrow drug discount patient definition: Drugmakers say an overly broad definition allows hospitals and other providers to claim more ...
axios.com/2026/04/08/abbvie-drug-discount-patient-lawsuit
STAT Apr 07
Pharmalittle: We’re reading about FDA backing domestic production, another Gilead deal, and more
statnews.com/pharmalot/2026/04/07/fda-backs-domestic-production-gilead-deal-merck-hiv-anthropic/
Paid articlePaywall
sabcnews.com Apr 05
WATCH | Nothemba Lumka, External Director at AbbVie, says Parkinson's disease is often overlooked, which delays the diagnostic process ... Show more
LinkedIn Mar 25
AbbVie | LinkedIn: AbbVie | 1.961.370 Follower:innen auf LinkedIn. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that ...
linkedin.com/company/abbvie
J&J’s new psoriasis pill to rival AbbVie’s Skyrizi: BNP Paribas: AbbVie (ABBV) stock dips as BNP warns J&J’s (JNJ) newly FDA-approved plaque psoriasis pill ...
seekingalpha.com/news/4565887-jjs-psoriasis-pill-rival-abbvies-skyrizi
Paid articlePaywall Fight against excess weight: AbbVie takes on Eli Lilly and Novo Nordisk: AbbVie reports positive study results for the appetite suppressant ABBV-295.
deraktionaer.de/artikel/pharma-biotech/kampf-gegen-pfunde-abbvie-nimmt-es-mit-eli-lilly-und-novo-nordisk-auf-20396896.html
Movers and Shakers: Central Bank, OpenAI, Kennedy Wilson, AbbVie, Viatel, Maples, Bedford Hotel
businesspost.ie/companies/movers-and-shakers-central-bank-openai-kennedy-wilson-abbvie-viatel-maples-bedford-hotel/
Paid articlePaywall AbbVie appoints new external engagement director
businesspost.ie/article/abbvie-appoints-new-external-engagement-director/
Paid articlePaywall STAT Feb 26
Justice Department backs AbbVie in its bid to overturn a Colorado law guiding a drug discount program
statnews.com/pharmalot/2026/02/26/justice-department-backs-abbvie-340b-hospitals-medicines-pharma/
Paid articlePaywall
AbbVie plans to spend $380 million building two new manufacuturing facilities in North Chicago
trib.al/MPqVrV8
AbbVie makes $380 million 'made in the U.S.' move: This is the next in the series of investments from AbbVie to expand U.S. pharmaceutical manufacturing.
thestreet.com/health/abbvie-makes-380-million-made-in-the-u-s-move
Hot Picks: Microsoft, AbbVie and PNC highlight dividend growth in AI: Microsoft, AbbVie and PNC highlighted as dividend large caps tied to AI growth ...
bnnbloomberg.ca/investing/hot-picks/2026/02/18/hot-picks-microsoft-abbvie-and-pnc-highlight-dividend-growth-in-ai/
AbbVie: Dominating Immunology While Building Oncology Upside: The total net revenues of AbbVie's Rinvoq and Skyrizi were about $25.87 billion in 2025, up 46 ...
seekingalpha.com/article/4870722-abbvie-dominating-immunology-while-building-oncology-upside
Paid articlePaywall
‘Molecular glue’ from this San Diego startup makes cancer self-destruct; Big Pharma bets billions
sandiegouniontribune.com/2026/02/03/molecular-glue-from-this-san-diego-startup-makes-cancer-self-destruct-big-pharma-bets-billions/
AbbVie forecasts 9.5% sales growth in 2026 amid blockbuster launches and pipeline momentum
seekingalpha.com/news/4547358-abbvie-forecasts-9_5-percent-sales-growth-in-2026-amid-blockbuster-launches-and-pipeline
Paid articlePaywall AbbVie shares tumble as Humira sales decline
businesspost.ie/article/abbvie-shares-tumble-as-humira-sales-decline/
Paid articlePaywall Earnings week ahead: AMZN, GOOG, PLTR, AMD, PFE, DIS, PYPL, ABBV, QCOM, SMCI, MRK, PEP, UBER, PM, and more
seekingalpha.com/news/4544709-earnings-week-ahead-amzn-goog-pltr-amd-pfe-dis-pypl-abbv-qcom-smci-mrk-pep-uber-pm-and-more
Paid articlePaywall Barron's Jan 23
AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next.
barrons.com/articles/abbvie-dodged-a-patent-disaster-and-shares-gained-460-merck-and-bristol-myers-are-next-5968f3cd
Paid articlePaywall Merck is said to halt acquisition talks with cancer drug developer Revolution: Merck ends Revolution Medicines acquisition talks over valuation.
seekingalpha.com/news/4542292-merck-is-said-to-halt-acquisition-talks-with-cancer-drug-developer-revolution
Paid articlePaywall
Trump administration strikes deal with AbbVie to cut costs of certain drugs: The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost ...
edition.cnn.com/2026/01/12/politics/drug-prices-abbvie-trump
AbbVie reaches deal with Trump administration on drug prices in exchange for tariff relief
trib.al/mPIIYGR
AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices
wsj.com/business/abbvie-strikes-100-billion-investment-deal-with-trump-will-lower-medicaid-prices-ffec5265
Paid articlePaywallMerck in talks to buy biotech Revolution in up to $32 billion deal, FT reports: Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 ...
reuters.com/business/healthcare-pharmaceuticals/merck-talks-buy-biotech-revolution-medicines-ft-reports-2026-01-08/
Barron's Jan 08
AbbVie Denies It’s in Talks to Buy Revolution Medicines. Both Stocks Are Falling.
barrons.com/articles/abbvie-stock-revolution-medicines-deal-60137788
Paid articlePaywall Merck in talks to acquire Revolution Medicines for about $30B - WSJ: Merck is in talks to buy Revolution Medicines for ~$30B, lifting RVBD shares 11%.
seekingalpha.com/news/4538147-merck-in-talks-to-acquire-revolution-medicines-for-about-30b-wsj
AbbVie: Solid Growth, Some Risks, And An Attractive Setup In 2026: Buy AbbVie (ABBV) stock? See more on its 2025 EPS growth outlook from Skyrizi/Rinvoq ...
seekingalpha.com/article/4856717-abbvie-solid-growth-some-risks-and-an-attractive-setup-in-2026
Paid articlePaywall Amazon is selling a home gym for just $400: The Marcy Home Gym is on sale at Amazon for 20% off, and it's the perfect way to kick off New Year's fitness goals.
thestreet.com/deals/marcy-home-gym-amazon-sale
Barron's Dec 14 25
A stronger economy and Fed rate cuts could provide tailwinds for dividend stocks next year. Consider buying names such as AbbVie, FedEx, and Coca-Cola.
LENZ plunges after adverse event report on eye therapy: LENZ Therapeutics (LENZ) stock drops as an FDA database indicates an adverse event linked to the ...
seekingalpha.com/news/4531128-lenz-stock-plunges-adverse-event-report
Paid articlePaywall AbbVie looks to reclaim some its Botox market share: AbbVie is hoping to attract customers with an enticing program.
thestreet.com/health/botox-maker-quietly-launches-plan-to-fend-off-rivals
Best Dividend Kings: November 2025: Discover which Dividend Kings are outperforming the S&P 500, recent dividend growth trends, and undervalued picks with strong ...
seekingalpha.com/article/4847621-best-dividend-kings-november-2025
Paid articlePaywall Russell 2000 Soars, Caps Volatile Week; AbbVie, BrightSpring, Alphatec In Focus | Stock Market Today
Barron's Oct 31 25
AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.: Revenue attributed to AbbVie’s oncology and aesthetics portfolio declined in the ...
barrons.com/articles/abbvie-earnings-stock-price-15008c13
Paid articlePaywall
'Baby' Botox, 'Natural' Filler Campaign Is Allergan Bid to Boost Sales
bloomberg.com/news/features/2025-11-13/botox-filler-sales-are-lagging-from-rise-of-natural-clean-girl-aesthetic
Paid articlePaywall Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer: Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure ...
seekingalpha.com/article/4840843-healthcare-q3-dividend-roundup-i-prefer-abbvie-over-pfizer
Paid articlePaywall
Federal judge won’t block Colorado prescription drug discount law: A federal judge declined to stop a Colorado law requiring drugmakers to offer discounted ...
denverpost.com/2025/11/05/colorado-lawsuit-340b-abbvie-pharmacy/
Purpose In The Pressure: Catherine Dargan On Building Billion-Dollar Deals: Catherine Dargan of Covington is a top lawyer in mergers & acquisitions and one of ...
forbes.com/sites/lianejackson/2025/11/04/purpose-in-the-pressure-catherine-dargan/
